{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:55:53Z","timestamp":1780340153094,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T00:00:00Z","timestamp":1579564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jhepr.2020.100080","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T00:16:50Z","timestamp":1580429810000},"page":"100080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer"],"prefix":"10.1016","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3447-1161","authenticated-orcid":false,"given":"Sven H.","family":"Loosen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie","family":"Breuer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Tacke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3730-5348","authenticated-orcid":false,"given":"Jakob N.","family":"Kather","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao","family":"Gorgulho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Alizai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bednarsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anjali A.","family":"Roeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Lurje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6732-1595","authenticated-orcid":false,"given":"Sophia M.","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7429-7412","authenticated-orcid":false,"given":"Jonathan F.","family":"Brozat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Paffenholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihael","family":"Vucur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Ritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trautwein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom F.","family":"Ulmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Roderburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Longerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf P.","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2020.100080_bib1","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2020.100080_bib2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.bpg.2015.02.003","article-title":"Epidemiology of cholangiocarcinoma","volume":"29","author":"Bergquist","year":"2015","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhepr.2020.100080_bib3","first-page":"95","article-title":"Cholangiocarcinoma \u2014 evolving concepts and therapeutic strategies","volume":"15","author":"Rizvi","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jhepr.2020.100080_bib4","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","article-title":"Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer","volume":"362","author":"Valle","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2020.100080_bib5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/annonc\/mdt540","article-title":"Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials","volume":"25","author":"Valle","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhepr.2020.100080_bib6","doi-asserted-by":"crossref","first-page":"996","DOI":"10.21037\/jgo.2016.09.10","article-title":"Advanced biliary tract cancer: clinical outcomes with ABC-02 regimen and analysis of prognostic factors in a tertiary care center in the United States","volume":"7","author":"Agarwal","year":"2016","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.jhepr.2020.100080_bib7","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.surg.2017.08.011","article-title":"Recurrence after curative-intent resection of perihilar cholangiocarcinoma: analysis of a large cohort with a close postoperative follow-up approach","volume":"163","author":"Komaya","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/j.jhepr.2020.100080_bib8","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1007\/s00268-016-3551-9","article-title":"Actual long-term survival outcome of 403 consecutive patients with hilar cholangiocarcinoma","volume":"40","author":"Kang","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/j.jhepr.2020.100080_bib9","first-page":"466","volume":"38","author":"Bi","year":"2016","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"10.1016\/j.jhepr.2020.100080_bib10","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.hpb.2016.04.001","article-title":"Conditional probability of long-term survival after resection of hilar cholangiocarcinoma","volume":"18","author":"Buettner","year":"2016","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.jhepr.2020.100080_bib11","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1056\/NEJMoa1809775","article-title":"FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer","volume":"379","author":"Conroy","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2020.100080_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2009\/504294","article-title":"suPAR: the molecular crystal ball","volume":"27","author":"Thun\u00f8","year":"2009","journal-title":"Dis Markers"},{"key":"10.1016\/j.jhepr.2020.100080_bib13","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/cc10037","article-title":"Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients","volume":"15","author":"Koch","year":"2011","journal-title":"Crit Care"},{"key":"10.1016\/j.jhepr.2020.100080_bib14","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s12032-013-0540-9","article-title":"Diagnostic and prognostic significance of CA IX and suPAR in gastric cancer","volume":"30","author":"Fidan","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/j.jhepr.2020.100080_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/liv.12705","article-title":"Serum soluble urokinase plasminogen activator receptor as a screening test for the early diagnosis of hepatocellular carcinoma","volume":"35","author":"Chounta","year":"2015","journal-title":"Liver Int"},{"issue":"43","key":"10.1016\/j.jhepr.2020.100080_bib16","doi-asserted-by":"crossref","first-page":"27027","DOI":"10.18632\/oncotarget.25471","article-title":"Serum levels of soluble urokinase plasminogen activator receptor (suPAR) predict outcome after resection of colorectal liver metastases","volume":"9","author":"Loosen","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jhepr.2020.100080_bib17","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.3748\/wjg.v10.i18.2750","article-title":"Relationship between urokinase-type plasminogen activator receptor and vascular endothelial growth factor expression and metastasis of gallbladder cancer","volume":"10","author":"Yue","year":"2004","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2020.100080_bib18","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3748\/wjg.v18.i3.244","article-title":"High level of urokinase plasminogen activator contributes to cholangiocarcinoma invasion and metastasis","volume":"18","author":"Thummarati","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhepr.2020.100080_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jhepr.2020.100080_bib20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00428-004-1118-x","article-title":"Factors of transforming growth factor beta signalling are co-regulated in human hepatocellular carcinoma","volume":"445","author":"Longerich","year":"2004","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jhepr.2020.100080_bib21","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/hep.22033","article-title":"Etiology-dependent molecular mechanisms in human hepatocarcinogenesis","volume":"47","author":"Schlaeger","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100080_bib22","doi-asserted-by":"crossref","first-page":"e51862","DOI":"10.1371\/journal.pone.0051862","article-title":"Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization","volume":"7","author":"Budczies","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2020.100080_bib23","doi-asserted-by":"crossref","first-page":"e0210399","DOI":"10.1371\/journal.pone.0210399","article-title":"Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma","volume":"14","author":"Hugdahl","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jhepr.2020.100080_bib24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1160\/TH11-12-0868","article-title":"The urokinase receptor (CD87) represents a central mediator of growth factor-induced endothelial cell migration","volume":"108","author":"Poettler","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhepr.2020.100080_bib25","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/hep.1840190629","article-title":"Classification of chronic hepatitis: diagnosis, grading and staging","volume":"19","author":"Desmet","year":"1994","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100080_bib26","first-page":"1911","article-title":"CX3CL1 promotes lung cancer cell migration and invasion via the Src\/focal adhesion kinase signaling pathway","volume":"41","author":"Liu","year":"2019","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jhepr.2020.100080_bib27","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/carcin\/bgt397","article-title":"CXCL5 contributes to tumor metastasis and recurrence of intrahepatic cholangiocarcinoma by recruiting infiltrative intratumoral neutrophils","volume":"35","author":"Zhou","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.jhepr.2020.100080_bib28","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/hep.20582","article-title":"Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts","volume":"41","author":"Isse","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2020.100080_bib29","first-page":"8376","article-title":"Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma","volume":"8","author":"Sun","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.jhepr.2020.100080_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40560-019-0381-5","article-title":"Neutrophils are a main source of circulating suPAR predicting outcome in critical illness","volume":"7","author":"Gussen","year":"2019","journal-title":"J\u00a0Intensive Care"},{"key":"10.1016\/j.jhepr.2020.100080_bib31","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1056\/NEJMoa1506362","article-title":"Soluble urokinase receptor and chronic kidney disease","volume":"373","author":"Hayek","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jhepr.2020.100080_bib32","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/ijms18081662","article-title":"Elevated soluble urokinase plasminogen activator receptor and proenkephalin serum levels predict the development of acute kidney injury after cardiac surgery","volume":"18","author":"Mossanen","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.jhepr.2020.100080_bib33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2217\/bmm-2015-0062","article-title":"Potential diagnostic and prognostic biomarkers for cholangiocarcinoma in serum and bile","volume":"10","author":"Wang","year":"2016","journal-title":"Biomark Med"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100080_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000488342","article-title":"Circulating biomarkers for cholangiocarcinoma","volume":"36","author":"Loosen","year":"2018","journal-title":"Dig Dis"},{"key":"10.1016\/j.jhepr.2020.100080_bib35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2559.1994.tb01291.x","article-title":"Immunohistochemical detection of the receptor for urokinase plasminogen activator in human colon cancer","volume":"24","author":"Pyke","year":"1994","journal-title":"Histopathology"},{"key":"10.1016\/j.jhepr.2020.100080_bib36","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1600-0676.1998.tb00826.x","article-title":"Stromal expression of urokinase-type plasminogen activator receptor (uPAR) is associated with invasive growth in primary liver cancer","volume":"18","author":"Akahane","year":"1998","journal-title":"Liver"},{"key":"10.1016\/j.jhepr.2020.100080_bib37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.bjc.6690678","article-title":"Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies","volume":"81","author":"Holst-Hansen","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhepr.2020.100080_bib38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ygyno.2005.09.038","article-title":"EGF-stimulated migration in ovarian cancer cells is associated with decreased internalization, increased surface expression, and increased shedding of the urokinase plasminogen activator receptor","volume":"101","author":"Henic","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jhepr.2020.100080_bib39","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/liv.12512","article-title":"Clinical relevance and cellular source of elevated soluble urokinase plasminogen activator receptor (suPAR) in acute liver failure","volume":"34","author":"Koch","year":"2014","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2020.100080_bib40","doi-asserted-by":"crossref","first-page":"3839","DOI":"10.1111\/febs.13894","article-title":"TLR2 promotes human intrahepatic cholangiocarcinoma cell migration and invasion by modulating NF-\u03baB pathway-mediated inflammatory responses","volume":"283","author":"Liu","year":"2016","journal-title":"FEBS J"},{"issue":"4","key":"10.1016\/j.jhepr.2020.100080_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/cjp2.135","article-title":"Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms","volume":"5","author":"Milione","year":"2019","journal-title":"J\u00a0Pathol Clin Res"},{"key":"10.1016\/j.jhepr.2020.100080_bib42","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S1535-6108(02)00072-7","article-title":"EGFR is a transducer of the urokinase receptor initiated signal that is required for in\u00a0vivo growth of a human carcinoma","volume":"1","author":"Liu","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jhepr.2020.100080_bib43","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1160\/TH15-01-0016","article-title":"PTEN expression in endothelial cells is down-regulated by uPAR to promote angiogenesis","volume":"114","author":"Unseld","year":"2015","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhepr.2020.100080_bib44","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.hpb.2016.04.004","article-title":"Acute kidney injury following hepatectomy for hepatocellular carcinoma: incidence, risk factors and prognostic value","volume":"18","author":"Lim","year":"2016","journal-title":"HPB"},{"key":"10.1016\/j.jhepr.2020.100080_bib45","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1093\/ckj\/sfs008","article-title":"Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges","volume":"5","author":"de Geus","year":"2012","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.jhepr.2020.100080_bib46","first-page":"3232848","article-title":"Soluble urokinase receptor and the kidney response in diabetes mellitus","volume":"2017","author":"Dande","year":"2017","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.jhepr.2020.100080_bib47","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/cc10037","article-title":"Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients","volume":"15","author":"Koch","year":"2011","journal-title":"Crit Care"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920300148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589555920300148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:23:56Z","timestamp":1762899836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589555920300148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2589555920300148"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100080","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating levels of soluble urokinase plasminogen activator receptor predict outcome after resection of biliary tract cancer","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2020.100080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"100080"}}